483
C.J. Labs, Inc.FDA 483 - C.J. Labs, Inc. - September 25, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of G&G Labs, Inc. in Miami, FL, from September 23-25, 2019, revealed a significant quality control deficiency. The firm failed to calibrate instruments and controls used in manufacturing and testing dietary supplements, including critical HPLC equipment. This indicates a systemic issue with ensuring the accuracy and precision of their testing processes.
Open in Dashboard
ID · 0dbaae0e-d973-496b-8def-8834aba1ea86